Weekly signal · ALAB · Technology

Astera Labs (ALAB) stacks a 216.4% 12-week gain in semiconductors

The cloud and AI connectivity-chip maker remains in an active weekly trend, with participation running only modestly above its recent average.

Astera Labs, Inc.
Latest367.15 USD
1W move15.8%
Volume1.1x
TrendActive
Semiconductor connectivity components and market data screens representing Astera Labs weekly market activity.

Market update

What happened

Astera Labs, Inc. (ALAB) closed the latest week at 367.15 USD, rising 15.8% for the week as the weekly price path over 52 weeks continued to point higher.

The confirmation is strong but not one-sided: Relative Strength stands at 82.8, Market Dynamics show confirmation at 1.62, and volume was 1.1x the 13-week average, making turnover supportive rather than extreme.

Continue your research

Explore ALAB across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.

ALAB coverage

Evidence context